Cargando…

Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas

BACKGROUND: Tumor hypoxia is theorized to contribute to the aggressive biology of pancreatic ductal adenocarcinoma (PDAC). We previously reported that hypoxia correlated with rapid tumor growth and metastasis in patient-derived xenografts. Anticipating a prognostic relevance of hypoxia in patient tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siddiqui, Iram, Bilkey, Jade, McKee, Trevor D., Serra, Stefano, Pintilie, Melania, Do, Trevor, Xu, Jing, Tsao, Ming-Sound, Gallinger, Steve, Hill, Richard P., Hedley, David W., Dhani, Neesha C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376475/ https://www.ncbi.nlm.nih.gov/pubmed/35978831 http://dx.doi.org/10.3389/fonc.2022.926497

Ejemplares similares

Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302
por: Lohse, Ines, et al.
Publicado: (2016)

Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole
por: Dhani, N C, et al.
Publicado: (2015)

Assessment of Hypoxia in the Stroma of Patient-Derived Pancreatic Tumor Xenografts
por: Lohse, Ines, et al.
Publicado: (2014)

Impact of tissue transport on PET hypoxia quantification in pancreatic tumours
por: Taylor, Edward, et al.
Publicado: (2017)

Lipocalin2 Promotes Invasion, Tumorigenicity and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
por: Leung, Lisa, et al.
Publicado: (2012)

Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx)
por: Chaudary, Naz, et al.
Publicado: (2012)

Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers
por: Pham, Nhu-An, et al.
Publicado: (2021)

Addition of multiple rare SNPs to known common variants improves the association between disease and gene in the Genetic Analysis Workshop 17 data
por: Sykes, Jenna, et al.
Publicado: (2011)

A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma
por: Aung, Kyaw L., et al.
Publicado: (2022)

Optimized application of penalized regression methods to diverse genomic data
por: Waldron, Levi, et al.
Publicado: (2011)

Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Khalvati, Farzad, et al.
Publicado: (2019)

Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Zhang, Yucheng, et al.
Publicado: (2020)

Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma
por: Radulovich, Nikolina, et al.
Publicado: (2010)

Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts
por: Weiss, Jessica, et al.
Publicado: (2022)

Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer
por: Gendoo, Deena M. A., et al.
Publicado: (2019)

FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma
por: Chung, Catherine T-S, et al.
Publicado: (2010)

Advances in the management of pancreatic ductal adenocarcinoma
por: O’Kane, Grainne M., et al.
Publicado: (2021)

Hedgehog inhibition enhances efficacy of radiation and cisplatin in orthotopic cervical cancer xenografts
por: Chaudary, Naz, et al.
Publicado: (2017)

Quantitative Visualization of Hypoxia and Proliferation Gradients Within Histological Tissue Sections
por: Zaidi, Mark, et al.
Publicado: (2019)

Intratumoral heterogeneity and hypoxia gene expression signatures: Is a single biopsy adequate?
por: Lukovic, Jelena, et al.
Publicado: (2019)

Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)
por: Dhont, Ludovic, et al.
Publicado: (2018)

Improving prognostic performance in resectable pancreatic ductal adenocarcinoma using radiomics and deep learning features fusion in CT images
por: Zhang, Yucheng, et al.
Publicado: (2021)

Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies
por: Starmans, Maud HW, et al.
Publicado: (2012)

BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts
por: Lohse, I, et al.
Publicado: (2015)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Circulating miR-16-5p, miR-92a-3p, and miR-451a in Plasma from Lung Cancer Patients: Potential Application in Early Detection and a Regulatory Role in Tumorigenesis Pathways
por: Reis, Patricia P., et al.
Publicado: (2020)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis
por: Pham, Nhu-An, et al.
Publicado: (2008)

Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts
por: Lohse, Ines, et al.
Publicado: (2016)

Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
por: Borst, Gerben R., et al.
Publicado: (2017)

Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
por: Borst, Gerben R., et al.
Publicado: (2020)

FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience
por: Chllamma, Muralidharan K, et al.
Publicado: (2016)

The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP)
por: Glicksman, Rachel, et al.
Publicado: (2017)

CNN-based survival model for pancreatic ductal adenocarcinoma in medical imaging
por: Zhang, Yucheng, et al.
Publicado: (2020)

Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
por: Ren, Min, et al.
Publicado: (2023)

Clinical significance of revised microscopic positive resection margin status in ductal adenocarcinoma of pancreatic head
por: You, Yunghun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2ili7di1k8d8cd44ibkt3c1rff